Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

4.03
-0.1950-4.62%
Post-market: 4.030.00000.00%19:40 EDT
Volume:956.15K
Turnover:3.94M
Market Cap:275.56M
PE:-0.76
High:4.30
Open:4.30
Low:4.02
Close:4.23
Loading ...

Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire
·
29 Jan

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic?

Simply Wall St.
·
19 Jan

Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
10 Jan

Insider Sellers Might Regret Selling Phathom Pharmaceuticals Shares at a Lower Price Than Current Market Value

Simply Wall St.
·
14 Dec 2024

Do You Believe in the Growth Potential of Phathom Pharmaceuticals (PHAT)?

Insider Monkey
·
12 Dec 2024

Craig-Hallum Remains a Buy on Phathom Pharmaceuticals (PHAT)

TIPRANKS
·
12 Dec 2024

Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
12 Dec 2024

Phathom Pharmaceuticals Files US FDA Petition to Seek Voquezna Exclusivity Period

MT Newswires Live
·
11 Dec 2024

BRIEF-Phathom Pharmaceuticals Submits Citizen Petition To FDA

Reuters
·
11 Dec 2024

Phathom Pharmaceuticals submits Citizen Petition to FDA

TIPRANKS
·
11 Dec 2024

Phathom Pharmaceuticals Inc: Exclusivity Period Is Until May 3, 2032

THOMSON REUTERS
·
11 Dec 2024

Phathom: Petition Requests Correction of Orange Book Listings for Voquezna 10 Mg,20 Mg Tablets to Accurately Reflect 10-Year Nce Exclusivity Period

THOMSON REUTERS
·
11 Dec 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for Voquezna® (Vonoprazan) Tablets

THOMSON REUTERS
·
11 Dec 2024

Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets

GlobeNewswire
·
11 Dec 2024

Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround

Zacks
·
06 Dec 2024

Phathom Pharmaceuticals Inc : Jefferies Cuts Target Price to $17 From $20

THOMSON REUTERS
·
05 Dec 2024

Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should Know

Zacks
·
20 Nov 2024

Phathom Pharmaceuticals (PHAT) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
11 Nov 2024

Phathom Pharmaceuticals Inc (PHAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
08 Nov 2024

Phathom Pharmaceuticals : Craig-Hallum Raises Target Price to $27 From $20

THOMSON REUTERS
·
08 Nov 2024